Schrodinger(SDGR)

Search documents
Schrodinger(SDGR) - 2022 Q1 - Quarterly Report
2022-05-03 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39206 Schrodinger, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 95-4284541 (State or other jurisdiction o ...
Schrodinger(SDGR) - 2021 Q4 - Earnings Call Presentation
2022-02-27 17:17
Transforming Discovery of Therapeutics and Materials February 24, 2022 Fourth Quarter and Full-Year 2021 Supplemental Slides Cautionary Note and Disclaimer This presentation contains certain "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 that involve substantial risks and uncertainties. All statements, other than statements of historical fact, contained in this presentation, including, without limitation, statements regarding the potential advant ...
Schrodinger(SDGR) - 2021 Q4 - Earnings Call Transcript
2022-02-25 04:22
Schrodinger, Inc. (NASDAQ:SDGR) Q4 2021 Earnings Conference Call February 24, 2022 5:00 PM ET Company Participants Ramy Farid - CEO, President & Director Jaren Madden - SVP, IR & Corporate Communications Joel Lebowitz - CFO & EVP Karen Akinsanya - EVP, Chief Biomedical Scientist and Head, Discovery R&D Conference Call Participants Do Kim - Piper Sandler Vikram Purohit - Morgan Stanley Andrew Tsai - Jefferies Lucas Baranowski - Craig-Hallum Capital Gary Nachman - BMO Capital Markets Derik De Bruin - Bank of ...
Schrodinger(SDGR) - 2021 Q4 - Annual Report
2022-02-23 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-39206 Schrodinger, Inc. (Exact name of Registrant as specified in its Charter) Delaware 95-4284541 (State or other jurisdiction of in ...
Schrodinger(SDGR) - 2021 Q3 - Earnings Call Transcript
2021-11-11 01:04
Schrödinger, Inc. (NASDAQ:SDGR) Q3 Earnings Conference Call November 10, 2021 4:30 PM ET Company Participants Ramy Farid – CEO Joel Lebowitz – CFO Karen Akinsanya – Executive Vice President Jaren Madden – Senior Vice President, IR Conference Call Participants Michael Ryskin – Bank of America Gary Nashman – BMO Capital Markets Matt Hewitt – Craig-Hallum Capital Group Gora Gabarachu – BMO Capital Michael Yee – Jefferies Operator Thank you for standing by. Welcome to Schrodinger's conference call to review the ...
Schrodinger(SDGR) - 2021 Q3 - Quarterly Report
2021-11-09 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39206 Schrodinger, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 95-4284541 (State or other jurisdicti ...
Schrodinger(SDGR) - 2021 Q2 - Earnings Call Transcript
2021-08-12 16:15
Schrödinger, Inc. (CSIQ) Q2 2021 Earnings Conference Call August 12, 2021 8:30 AM ET Company Participants Ramy Farid – President and CEO Tracy Lessor – Executive Director of Corporate Communications Karen Akinsanya – Executive Vice President, Chief Biomedical Scientists, and Head of Discovery R&D Joel Lebowitz – Executive Vice President and CFO Conference Call Participants Michael Yee – Jefferies Michael Ryskin – Bank of America Gary Nashman – BMO Capital Markets David Lebowitz – Morgan Stanley Matt Hewitt ...
Schrodinger(SDGR) - 2021 Q2 - Quarterly Report
2021-08-11 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39206 Schrodinger, Inc. (Exact Name of Registrant as Specified in its Charter) | Delaware | 95-4284541 | | --- | --- | | (State or ...
Schrodinger(SDGR) - 2021 Q1 - Earnings Call Transcript
2021-05-11 16:54
Schrödinger, Inc. (NASDAQ:SDGR) Q1 2021 Earnings Conference Call May 11, 2021 8:30 AM ET Company Participants Jaren Madden - Senior Vice President, Investor Relations and Corporate Communications Ramy Farid - President and CEO Karen Akinsanya - Executive Vice President, CBS and Head, Discovery R&D Joel Lebowitz - Executive Vice President and CFO Conference Call Participants Michael Yee - Jefferies Michael Ryskin - Bank of America Do Kim - BMO Capital Markets David Lebowitz - Morgan Stanley Operator Thank yo ...
Schrodinger(SDGR) - 2021 Q1 - Quarterly Report
2021-05-10 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39206 Schrodinger, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 95-4284541 (State or other jurisdiction o ...